Incyte Corp at Cowen Health Care Conference Transcript

Mar 06, 2023 / 04:10PM GMT
Marc Alan Frahm - Cowen and Company, LLC, Research Division - MD & Analyst

Healthcare Conference. I'm Marc Frahm, the biotech team. Next up, we're really pleased to have with us CFO from Incyte , Christiana Stamoulis; and the General Manager of North America, Barry Flannelly.

Questions and Answers:

Marc Alan Frahm - Cowen and Company, LLC, Research Division - MD & Analyst

So maybe to start off, Christiana, you want to just kind of level set people on, insight status updates and kind of what are the major updates you're looking to over the next 6, 12 months?

Christiana Stamoulis - Incyte Corporation - Executive VP & CFO

Sure. So as you may recall from our earnings call this last month, we had progress along a number of different fronts in 2022 that we are looking to continue in '23. First, on the commercial end, very important was the progress of the Opzelura launch both in AD as well as in vitiligo, which was the indication that we got approval for in 2022.

We are very much looking forward
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
4.6 out of 5 Trustpilot